AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 61 min read$OPCH

OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover

Option Care Health (OPCH) shares surged 34% after CD&R and McKesson agreed to acquire it for $32.05 per share, valuing the company at $5.8B including debt. CD&R will hold 51% stake, McKesson 49%.

Original reporting
tradingview.com
Published Oct 6, 2026, 12:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 1:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover — source image
Source · tradingview.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The acquisition creates a vertically integrated platform, potentially improving cost efficiencies and market reach.

02

Market read

The deal is a material M&A event in the U.S. healthcare sector, prompting a sharp stock rally and potential ripple effects for peers.

03

What to watch

Financing terms and post‑closing performance of the combined entity are not disclosed.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Option Care Health provides home health and hospice services; CD&R is a private equity firm and McKesson a large healthcare distributor.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a definitive $5.8B acquisition by CD&R and McKesson, driving a 34% share jump.

Expected impact

upward pressure as market prices in the acquisition premium.

Evidence & confidence

First report of the transaction, sizable premium and immediate 34% price move.

Market effects

Sector

Consolidation in the home health services sector may prompt valuation reassessments for peers.

Regional

U.S. healthcare market sees increased M&A activity, potentially boosting related REITs.

Global

Limited to U.S. healthcare investors; no broader macro effect.

Counterpoint

What could challenge this read

Deal could face regulatory scrutiny or integration risk, which may temper the rally.

Key entities

  • company
    Option Care Health

    Target of the $5.8B acquisition.

  • private equity
    CD&R

    Majority stakeholder acquiring ~51% of OPCH.

  • company
    McKesson

    Minority investor acquiring ~49% of OPCH.

Read at source← All news

Also covered by

5 outlets

Related articles

OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min
OCT 7
$OPCHHighAI 9/10

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

finance.yahoo.com2 min
OCT 7
$MCKHighAI 9/10

McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout

McKesson plans a $1.4B investment for a 49% stake in Option Care Health, part of a $5.8B buyout by Clayton, Dubilier & Rice. Shareholders will receive $32.05 per share. The deal, pending approvals, is expected to close in early 2027. Option Care shares rose 32.7% on the news. McKesson's Q1 revenue grew 8% to $105.4B, with net income down 22% to $614M.

finchannel.com2 min